Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FANCB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
STRBP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NT5M - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR43 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AP4S1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ACTR3BP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PGAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NOC2L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTGER3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RASAL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EME1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
METAP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NSL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTIF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
NT5DC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL12B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYFIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
THAP7-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on